Table 1.
Criteria | EASL 2012[6] | AASLD 2009[7] | APASL 2012[8] |
HBV DNA treatment threshold | |||
HBeAg(+) (IU/mL) | 2000 | 20000 | 20000 |
HBeAg(-) (IU/mL) | 2000 | 2000-20000 | 2000 |
ALT treatment threshold | > ULN | > 2 × ULN | > 2 × ULN |
Liver biopsy | Moderate to severe necroinflammation or fibrosis | Not applicable (consider in certain groups) |
ULN: Upper limits of normal; HBeAg: Hepatitis B e antigen; ALT: Alanine aminotransferase; AASLD: American Association for the Study of Liver Diseases; APASL: Asia Pacific Association for the Study of the Liver; EASL: European Association for the Study of the Liver; HBV: Hepatitis B virus.